What is Selank?

• What Selank is and how it was built from the immunopeptide tuftsin
• Its multimodal mechanism: GABA modulation, enkephalinase inhibition, serotonin, and BDNF
• What the Russian clinical trials showed, and why the English-language evidence is thin
• Its regulatory reality: registered in Russia, not approved in the US, and the 503A saga

1. 01 What is Selank? A Russian anxiety peptide built from an immune molecule free
2. 02 The tuftsin origin story From a 1970 immune discovery to a Moscow anxiety peptide paid
3. 03 How it calms: GABA & enkephalin Calming the brain without hijacking it paid
4. 04 BDNF, serotonin & cognition Beyond calm: growth factors and mood chemistry paid
5. 05 The immune inheritance What Selank kept from its immune ancestor paid
6. 06 The clinical evidence A real clinical record, in the wrong language paid
7. 07 Chemistry & nose-to-brain delivery Seven residues, three prolines, and a path to the brain paid
8. 08 Safety & Side Effects A gentle profile, honestly qualified paid
9. 09 Dosing & Administration What the label says, and why the brain sees less paid
10. 10 Regulatory landscape One molecule, a patchwork of legal realities paid
11. 11 Final Exam & Certification Pass the final exam to earn your specialist certificate. Exam

Selank is a redesigned immune peptide. Russian chemists started with tuftsin, a natural four-amino-acid molecule your body cuts from antibodies to rally immune cells, and extended it with a small protective tail. The redesign kept part of the original biology but pulled out a new, calming effect on the brain. The result is a seven-amino-acid peptide used as a nasal anxiety treatment in Russia.

The key idea is that a tiny structural change unlocked a very different use. Tuftsin is an immune stimulant that lasts only minutes; adding the Pro-Gly-Pro tail slowed its breakdown and shifted the emphasis toward the brain and stress systems. Selank is best understood as tuftsin's calmer, longer-lasting cousin, not as a copy of any Western anxiety drug.

The most common misconception is that Selank is "a benzodiazepine you can't get addicted to." That is wrong. Benzodiazepines like Xanax directly flip on the brain's GABA-A receptors, which is what makes them fast, sedating, and dependence-forming. Selank does not flip that switch. Radioligand work places its site elsewhere (the authors describe the two sites as apparently not the same, though they may partially overlap), and it nudges the same systems indirectly, which is why its profile looks so different.

This distinction matters for expectations and safety. A benzodiazepine works in minutes and sedates because it forces the receptor open; Selank works more gently because it changes how the system is tuned rather than seizing the controls. That indirect action is the honest basis for the "no-benzo profile" claim, though as later units show, it has not been proven in modern Western trials.

Selank does not have a single mechanism. It touches several stress- and mood-relevant systems at once, which is why researchers call it a polypharmacological neuropeptide. Seeing all the pillars together up front makes the rest of the course easier to follow, since each later unit zooms into one of them.

No single pillar is the whole answer, and that is the point. A benzodiazepine has one dominant mechanism; Selank spreads its effect across five weaker levers. That breadth may explain both its gentle, non-sedating feel and the difficulty of pinning down exactly how it works, a recurring theme when the evidence gets examined honestly.

Selank's legal status is genuinely split by geography. In Russia it is a registered pharmaceutical with a specific approved use; in the United States it has no approval at all and circulates as a research peptide. Understanding this divide is essential before reading any claim about its safety or effectiveness.

This is not a technicality. In Russia, a patient gets a quality-controlled product with a defined dose and indication. In the US, a buyer gets a vial from the research-peptide market with no guarantee of identity, purity, or dose. The same molecule can be a regulated medicine or an unregulated gamble depending on where you are.

Selank sits in an unusual evidence position: stronger than internet hype, weaker than an FDA-approved drug. Its mechanism has real English-language studies, its anxiety data are real but mostly Russian-language, and its US market is uncontrolled. This course keeps those three tiers strictly separate instead of blurring them into marketing.

Keep these tiers in mind for the whole course. The mechanism story is worth taking seriously, the Russian clinical record is substantial but linguistically siloed, and the modern English trial base is genuinely thin. Honest education names that structure plainly rather than rounding Selank up to "proven" or down to "snake oil."